Cargando…
N-methyl D-aspartate receptor subtype 2B antagonist, Ro 25-6981, attenuates neuropathic pain by inhibiting postsynaptic density 95 expression
Postsynaptic density-95 (PSD-95) is a synaptic scaffolding protein that plays a crucial role in the development of neuropathic pain. However, the underlying mechanism remains unclear. To address the role of PSD-95 in N-methyl-D-aspartate receptor subtype 2B (NR2B) -mediated chronic pain, we investig...
Autores principales: | Huang, Ling-Er, Guo, Shao-Hui, Thitiseranee, Lalita, Yang, Yan, Zhou, Yan-Feng, Yao, Yong-Xing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959906/ https://www.ncbi.nlm.nih.gov/pubmed/29777135 http://dx.doi.org/10.1038/s41598-018-26209-7 |
Ejemplares similares
-
NMDA receptor antagonists ketamine and Ro25-6981 inhibit evoked release of glutamate in vivo in the subiculum
por: Stan, T L, et al.
Publicado: (2014) -
Ketamine and Ro 25-6981 Reverse Behavioral Abnormalities in Rats Subjected to Dietary Zinc Restriction
por: Pochwat, Bartłomiej, et al.
Publicado: (2020) -
The GluN2B-Selective Antagonist Ro 25-6981 Is Effective against PTZ-Induced Seizures and Safe for Further Development in Infantile Rats
por: Mareš, Pavel, et al.
Publicado: (2021) -
Structural connectivity and subcellular changes after antidepressant doses of ketamine and Ro 25-6981 in the rat: an MRI and immuno-labeling study
por: Pascual-Antón, Raquel, et al.
Publicado: (2021) -
The Neurogenesis Actuator and NR2B/NMDA Receptor Antagonist Ro25-6981 Consistently Improves Spatial Memory Retraining Via Brain Region-Specific Gene Expression
por: Gruden, Marina A., et al.
Publicado: (2018)